New York State Common Retirement Fund’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.09M Hold
92,497
0.01% 1063
2025
Q1
$6.54M Sell
92,497
-1,148
-1% -$81.2K 0.01% 923
2024
Q4
$6.16M Sell
93,645
-4,600
-5% -$302K 0.01% 1018
2024
Q3
$6.91M Sell
98,245
-201,334
-67% -$14.2M 0.01% 955
2024
Q2
$24.7M Buy
299,579
+2,530
+0.9% +$208K 0.03% 419
2024
Q1
$25.9M Sell
297,049
-17,690
-6% -$1.55M 0.03% 426
2023
Q4
$30.3M Sell
314,739
-16,537
-5% -$1.59M 0.04% 364
2023
Q3
$29.3M Buy
331,276
+29,043
+10% +$2.57M 0.04% 366
2023
Q2
$26.2M Sell
302,233
-2,505
-0.8% -$217K 0.03% 453
2023
Q1
$29.6M Sell
304,738
-12,607
-4% -$1.23M 0.04% 408
2022
Q4
$32.8M Sell
317,345
-64,922
-17% -$6.72M 0.05% 366
2022
Q3
$32.4M Sell
382,267
-4,904
-1% -$416K 0.05% 358
2022
Q2
$32.1M Sell
387,171
-9,338
-2% -$774K 0.04% 368
2022
Q1
$30.6M Buy
396,509
+114,048
+40% +$8.79M 0.03% 447
2021
Q4
$25M Buy
282,461
+3,673
+1% +$325K 0.03% 559
2021
Q3
$21.5M Sell
278,788
-144,826
-34% -$11.2M 0.02% 639
2021
Q2
$35.3M Sell
423,614
-325
-0.1% -$27.1K 0.04% 438
2021
Q1
$32M Sell
423,939
-32,951
-7% -$2.49M 0.04% 458
2020
Q4
$40.1M Sell
456,890
-29,400
-6% -$2.58M 0.04% 390
2020
Q3
$37M Buy
486,290
+47,487
+11% +$3.61M 0.05% 371
2020
Q2
$54.1M Buy
438,803
+15,316
+4% +$1.89M 0.07% 270
2020
Q1
$35.8M Buy
423,487
+24,398
+6% +$2.06M 0.05% 318
2019
Q4
$33.7M Sell
399,089
-4,600
-1% -$389K 0.04% 434
2019
Q3
$27.2M Buy
403,689
+71,689
+22% +$4.83M 0.03% 502
2019
Q2
$28.4M Sell
332,000
-2,400
-0.7% -$206K 0.04% 503
2019
Q1
$29.7M Sell
334,400
-50,025
-13% -$4.44M 0.04% 467
2018
Q4
$32.7M Sell
384,425
-90,990
-19% -$7.75M 0.05% 383
2018
Q3
$46.1M Hold
475,415
0.05% 340
2018
Q2
$44.8M Buy
475,415
+825
+0.2% +$77.7K 0.06% 331
2018
Q1
$38.5M Sell
474,590
-10,000
-2% -$811K 0.05% 406
2017
Q4
$43.2M Sell
484,590
-1,200
-0.2% -$107K 0.05% 374
2017
Q3
$45.2M Buy
485,790
+7,000
+1% +$651K 0.06% 336
2017
Q2
$43.5M Sell
478,790
-5,724
-1% -$520K 0.06% 336
2017
Q1
$42.5M Sell
484,514
-22,426
-4% -$1.97M 0.06% 344
2016
Q4
$42M Buy
506,940
+36,000
+8% +$2.98M 0.06% 328
2016
Q3
$43.6M Buy
470,940
+77,540
+20% +$7.17M 0.06% 314
2016
Q2
$30.6M Buy
393,400
+31,400
+9% +$2.44M 0.04% 438
2016
Q1
$29.9M Sell
362,000
-70,300
-16% -$5.8M 0.05% 426
2015
Q4
$45.3M Buy
432,300
+5,100
+1% +$534K 0.07% 284
2015
Q3
$45M Buy
427,200
+262,144
+159% +$27.6M 0.07% 276
2015
Q2
$22.6M Buy
165,056
+117,056
+244% +$16M 0.03% 543
2015
Q1
$5.98M Buy
48,000
+46,486
+3,070% +$5.79M 0.01% 1115
2014
Q4
$137K Sell
1,514
-32,323
-96% -$2.92M ﹤0.01% 1998
2014
Q3
$2.44M Sell
33,837
-18,463
-35% -$1.33M ﹤0.01% 1527
2014
Q2
$3.25M Sell
52,300
-54,600
-51% -$3.4M ﹤0.01% 1454
2014
Q1
$7.29M Hold
106,900
0.01% 1059
2013
Q4
$7.51M Buy
106,900
+14,400
+16% +$1.01M 0.01% 1035
2013
Q3
$6.68M Sell
92,500
-800
-0.9% -$57.8K 0.01% 1045
2013
Q2
$5.21M Buy
+93,300
New +$5.21M 0.01% 1074